Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- ChecktodayChange DetectedAdministrative updates were made to the study record dates, adding 2026-03-25 and 2026-03-24 and removing 2026-03-18 and 2026-03-19.SummaryDifference0.1%

- Check7 days agoChange DetectedAdded Informed Consent Form PDFs for Phase I, Phase 2A, and Phase 2B under Study Documents. The revision version is v3.5.0.SummaryDifference0.9%

- Check14 days agoChange DetectedNew update entries dated 2026-03-11 and 2026-03-12 for revision v3.4.3 were added, and the prior revision v3.4.2 was removed. The visible study content and page functionality appear unaffected.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded update dates 2026-03-04 and 2026-03-05 and removed 2026-02-24 and 2026-02-25 from the page's update history.SummaryDifference0.1%

- Check29 days agoChange DetectedThe study record timeline was updated to include new dates (2026-02-24 and 2026-02-25) and remove earlier dates (2026-02-17 and 2026-02-18).SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's update history now shows new dates (2026-02-17 and 2026-02-18) and removes older dates (2026-02-10 and 2026-02-11); the changes affect only the update timeline and not the core study details.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.